Stem cell divisions controlled by the proto-oncogene BMI-1

Journal of Stem Cells

Volumn 4, Issue 3, 2009, Pages 141-146

  Grinstein, Edgar ^a   Mahotka, Csaba ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; BMI1 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; REPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

CANCER STEM CELL; CELL DIVISION; CELL RENEWAL; GENE FUNCTION; HUMAN; NONHUMAN; PROTEIN FUNCTION; PROTO ONCOGENE; PROTO ONCOGENE BMI1; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; ANIMAL; METABOLISM; NEOPLASM; PATHOLOGY; REGENERATION;

ANIMALS; CELL DIVISION; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REGENERATION; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; STEM CELLS; TUMOR SUPPRESSOR PROTEINS;

EID: 77950344603     PISSN: 15568539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Al-Hajj, M; Wicha, MS; Benito-Hernandez, A; Morrison, SJ; Clarke, MF. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 3983-3988. (Pubitemid 36418143)
2. Bartek, J; Bartkova, I; Lukas, J. The retinoblastoma protein pathway and the restriction point. Curr. Opin. Cell Biol. 1996, 8, 805-814. (Pubitemid 26399940)
3. Beachy, PA; Karhadkar, SS; Berman, DM. Tissue repair and stem cell renewal in carcinogenesis. Nature, 2004, 432, 324-331. (Pubitemid 39551660)
4. Bonnet, D; Dick, JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med., 1997, 3, 730-737.
5. Bracken, AP; Dietrich, N; Pasini, D; Hansen, K H; Helin, K. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev., 2006, 20, 1123-1136.
6. Bracken, AP; Kleine-Kohlbrecher, D; Dietrich, N; Pasini, D; Gargiulo, G; Beekman, C; Theilgaard-Monch, K; Minucci, S; Porse, BT; Marine, J-C; Hansen, K H; Helin, K. The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev., 2007, 21, 525-530. (Pubitemid 46409467)
7. Brown, L; Boswell, S; Raj, L; Lee, SW. Transcriptional targets of p53 that regulate cellular proliferation. Crit. Rev. Eukaryot. Gene Expr., 2007,17, 73-85.
8. Bruggeman, SW; Valk-Lingbeek, ME; van der Stoop, PP; Jacobs, JJ; Kieboom, K; Tanger, E; Hulsman, D; Leung, C; Arsenijevic, Y;. Marino, S; van Lohuizen, M. Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. Genes Dev., 2005, 19, 1438-1443.
9. Campisi, J. Senescent Cells, Tumor Suppression, and Organismal Aging: Good Citizens, Bad Neighbors. Cell, 2005, 120, 513-522.
10. Carnero, A; Hudson, JD; Price, CM; Beach, DH. p16INK4A and p19ARF act in overlapping pathways in cellular immortalization. Nat. Cell Biol., 2000, 2, 148-155.
11. Clarke, MF; Fuller, M. Stem cells and cancer: two faces of eve. Cell, 2006, 124, 1111-1115.
12. Collins, AT; Berry, PA; Hyde, C; Stower, MJ; Maitland, NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res., 2005, 65, 10946-10951. (Pubitemid 41713363)
13. Cui, H; Ma, J; Ding, J; Li, T; Alam, G; Ding, HF. Bmi-1 regulates the differentiation and clonogenic self-renewal of I-type neuroblastoma cells in a concentration-dependent manner. J Biol Chem., 2006, 28, 34696-34704.
14. Cui, H; Hu, B; Li, T; Ma, J; Alam, G; Gunning, WT; Ding, HF. Bmi-1 is essential for the tumorigenicity of neuroblastoma cells. Am. J. Pathol., 2007, 170, 1370-1378.
15. Czermin, B; Melfi, R; McCabe, D; Seitz, V; Imhof, A; Pirrotta, V. Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell, 111, 2002, 185-196. (Pubitemid 35292439)
16. de Stanchina, E; McCurrach, ME; Zindy, F; Shieh, SY; Ferbeyre, G; Samuelson, AV; Prives, C; Roussel, MF; Sherr, CJ; Lowe, SW. E1A signaling to p53 involves the p19ARF tumor suppressor. Genes Dev., 1998, 12, 2434-2442.
17. Doherty, JM; Geske, MJ; Stappenbeck, TS; Mills JC. Diverse Adult Stem Cells Share Specific Higher-Order Patterns of Gene Expression. Stem Cells, 2008, 26, 2124-2130.
18. Eramo, A; Lotti, F; Sette, G; Pilozzi, E; Biffoni, M; Di Virgilio, A; Conticello, C; Ruco, L; Peschle, C; De Maria, R. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ., 2008, 15, 504-514.
19. Fasano, CA; Dimos, JT; Ivanova, NB; Lowry, N; Lemischka, IR; Temple, S. shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development. Cell Stem Cell, 2007; 1, 87-99.
20. Grinstein, E; Wernet, P. Cellular signaling in normal and cancerous stem cells. Cellular Signalling, 2007, 19, 2428-2433. (Pubitemid 47531926)
21. Harbour, JW; Dean, DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev., 2000, 14, 2393-2409.
22. Haupt, Y; Alexander, WS; Barri, G; Klinken, SP; Adams, JM. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Eμ-myc transgenic mice. Cell, 1991, 65, 753-763.
23. Hemmati, HD; Nakano, I; Lazareff, JA; Masterman-Smith, M; Geschwind, DH; Bronner-Fraser, M; Kornblum, HI. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. U.S.A., 2003, 100, 15178-1583.
24. Hickman, ES; Moroni, MC, Helin, K. The role of p53 and pRB in apoptosis and cancer. Curr. Opin. Genet. Dev., 2002, 12, 60-66. (Pubitemid 34094991)
25. Hope, KJ; Jin, L; Dick, JE. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nature Immunol., 2004, 5, 738-743.
26. INK4a Nature, 2006, 443, 421-426.
27. Kamijo, T; Zindy, F; Roussel, MF; Quelle, DE; Downing, JR; Ashmun, RA; Grosveld, G; Sherr, CJ. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell, 1997, 91, 649-659.
28. Klein, S; McCormick, F; Levitzki, A. Killing time for cancer cells. Nature Rev. Cancer., 2005, 5, 573-580.
29. Krishnamurthy, J; Torrice, C; Ramsey, MR; Kovalev, GI; Al-Regaiey, K; Su, L; Sharpless, NE. Ink4a/Arf expression is a biomarker of aging. J. Clin. Invest., 2004, 114, 1299-1307.
30. Krishnamurthy, J; Ramsey, MR;. Ligon, KL; Torrice, C; Koh, A; Bonner-Weir, SN; Sharpless, E. p16INK4a induces an age-dependent decline in islet regenerative potential. Nature, 2006, 443, 453-457.
31. Lessard, J; Baban, S; Sauvageau, G. Stage-specific expression of polycomb group genes in human bone marrow cells. Blood, 1998, 91, 1216-1224. (Pubitemid 28086874)
32. Lessard, J; Sauvageau, G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells Nature, 2003, 423, 255-260. (Pubitemid 40852690)
33. Leung, C; Lingbeek, M; Shakhova, O; Liu, J; Tanger, E; Saremaslani, P; van Lohuizen, M; Marino, S. BMI1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature, 2004, 428, 337-341. (Pubitemid 38418806)
34. Levine, AJ. p53, the Cellular Gatekeeper for Growth and Division. Cell, 1997, 88, 323-331.
35. Lowe, SW; Sherr, CJ. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev., 2003, 13, 77-83.
36. Matheu, A; Maraver, A; Klatt, P; Flores, I; Garcia-Cao, I; Borras, C; Flores, JM; Vina, J; Blasco, MA; Serrano, M. Delayed ageing through damage protection by the Arf/p53 pathway. Nature, 2007, 448, 375-379. (Pubitemid 47080339)
37. Molofsky, AV; Pardal, RT; Iwashita, Park, I-K; Clarke, MF; Morrison, SJ. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature, 2003, 425, 962-967.
38. Arf senescence pathways. Genes Dev., 2005, 19, 1432-1437.
39. Molofsky, AV; Slutsky, SG; Joseph, NM; He, S; Pardal, R; Krishnamurthy, J; Sharpless, NE; Morrison, SJ. Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing. Nature, 2006, 443, 448-452.
40. Moore, L; Venkatachalam, S; Vogel, H; Watt, JC; Wu, CL; Steinman, H; Jones, SN; Donehower, LA. Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis. Oncogene, 2003, 22, 7831-7837.
41. O'Brien, CA; Pollett, A; Gallinger, S; Dick, JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 2007, 445, 106-110.
42. Oguro, H; Iwama, A; Morita, Y; Kamijo, T; van Lohuizen, M; Nakauchi. H.. Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice. J. Exp. Med., 2006, 203, 2247-2253. (Pubitemid 44498359)
43. Park, I-K; Dalong, Q; Kiel, M; Becker, MW; Pihalja, M; Weissman, IL; Morrison, SJ; Clarke, MF. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature, 2003, 423, 302-305.
44. Passegue, E; Jamieson, CH; Ailles, LE; Weissman, IL. Normal and leukemic hematopoiesis: Are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc. Natl. Acad. Sci. U.S.A., 2003, 100 ,11842-11849.
45. Quelle, DE; Zindy, F; Ashmun, RA.; Sherr, CJ. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 1995, 83, 993-1000.
46. Raaphorst, FM. Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors. Hum. Mol. Genet., 2005, 14, R93-R100
47. Reya, T; Morrison, SJ; Clarke, MF; Weissman, IL. Stem cells, cancer, and cancer stem cells. Nature, 2001, 414, 105-111.
48. Reya, T; Clevers, H. Wnt signalling in stem cells and cancer. Nature, 2005, 434, 843-850. (Pubitemid 40558990)
49. Sharpless, NE; Bardeesy, N; Lee, K-H; Carrasco, D; Castrillon, DH; Aguirre, AJ; Wu, EA; Horner, W; DePinho, RA. Loss of p16 with retention of p19 predisposes mice to tumorigenesis. Nature, 2001, 413, 86-91.
50. Sharpless, NE; Ramsey, MR; Balasubramanian, P; Castrillon, DH; DePinho, RA. The differential impact of p16 or p19 deficiency on cell growth and tumorigenesis. Oncogene, 2004, 23, 379-385.
51. Sharpless, NE; DePinho, RA. Telomeres, stem cells, senescence, and cancer. J. Clin. Invest., 2004, 113, 160-168.
52. Sherr, CJ. Cancer cell cycles. Science, 1996, 274, 1672-1677.
53. Sherr, CJ. The INK4a/ARF network in tumour suppression. Nature Rev Mol Cell Biol., 2001, 2, 731-737.
54. Sherr, CJ; McCormick, F. The RB and p53 pathways in cancer. Cancer Cell, 2002, 2, 103-112.
55. Shi Y; Sun G; Zhao C; Stewart R. Neural stem cell self-renewal. Crit Rev Oncol Hematol. 2008, 65, 43-53.
56. Valk-Lingbeek, ME; Bruggeman, SWM; Van Lohuizen, M. Stem cells and cancer: The polycomb connection. Cell, 2004, 118,409-418. (Pubitemid 39485661)
57. Van der Lugt, NMT; Domen, J; Linders, K; Van Roon, M; Robanus-Maandag, E; Te Riele, H; Van der Valk, M; Deschamps, M; Sofroniew, M; van Lohuizen, Berns, A. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto- oncogene. Genes Dev., 1994, 8, 757-769. (Pubitemid 24985778)
58. Van Galen, JC; Muris, JJF; Oudejans, JJ; Vos, W; Giroth, CPE; Ossenkoppele, GJ; Otte, AP; Raaphorst, FM;Meijer,CJLM. Expression of the polycomb-group gene BMI1 is related to an unfavourable prognosis in primary nodal DLBCL. J. Clin. Pathol., 2007, 60, 167-172. (Pubitemid 46245780)
59. Wong, DJ; Liu, H; Ridky, TW; Cassarino, D; Segal, E; Chang, HY. Module map of stem cell genes guides creation of epithelial cancer stem cells. Cell Stem Cell, 2008; 2, 333-344.
60. Zindy, F; Quelle, DE; Roussel, MF; Sherr, CJ. Expression of the p16(INK4a) tumor suppressor versus other INK4 family members during mouse development and aging. Oncogene, 1997, 15, 203-211.
61. Zindy, F; Eischen, CM; Randle, DH; Kamijo, T; Cleveland, JL; Sherr, CJ; Roussel, MF. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev., 1998, 12, 2424-2433.
62. Zon LI. Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature, 2008, 453, 306-313.